APPLICATION
ANDA077921
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-19
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
MELOXICAMPrescription
MELOXICAM 7.5MG · TABLET · ORAL
MELOXICAMPrescription
MELOXICAM 15MG · TABLET · ORAL
Approval history
2024-11-21Labeling · Supplement 38 · standardAP
2023-01-05Labeling · Supplement 34 · standardAP
2016-08-15Labeling · Supplement 30 · standardAP
2016-08-15Labeling · Supplement 29 · standardAP
2016-04-20Manufacturing (CMC) · Supplement 14AP
2015-09-10Labeling · Supplement 17AP
2015-09-10Labeling · Supplement 21 · standardAP
2015-09-10Labeling · Supplement 18AP
2014-09-03Labeling · Supplement 9AP
2010-10-26Labeling · Supplement 15AP
2010-10-26Labeling · Supplement 13AP
2010-08-27Labeling · Supplement 12AP
2008-09-23Labeling · Supplement 7AP
2007-11-20Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.